As on (02 Mar 2024 | 03:23)
Back To Homepage As on (02 Mar 2024 | 03:23)
Sun Pharma to acquire balance stake in its Mexican subsidiary Back
(28 Sep 2023)
Sun Pharmaceutical Industries announced that one of its subsidiary companies has signed a binding letter of intent to acquire the balance 25% outstanding shares of Sun Pharma de México, S.A. de C.V., a subsidiary of the Company, where the Company is currently holding 75% shares.

Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the Company.

Top